Diabetes Archives - Pharmaphorum

Study shows AZ’s Farxiga diabetes drug cuts heart risks

https://pharmaphorum.com/news/study-shows-azs-farxiga-diabetes-drug-cuts-heart-risks/

Novo Nordisk lays off 400 staff in R&D shake-up

https://pharmaphorum.com/news/novo-nordisk-lays-off-400-staff-in-rd-shake-up/

Novo Nordisk CEO reassures UK patients over Brexit insulin supplies

https://pharmaphorum.com/news/novo-nordisk-doubles-uk-insulin-stockpile-in-case-of-no-deal-brexit/

Can pharma halt the world’s obesity crisis?

https://pharmaphorum.com/views-and-analysis/can-pharma-halt-the-worlds-obesity-crisis/

Adocia and Lilly’s legal tussle intensifies as diabetes deal goes wrong

https://pharmaphorum.com/news/adocia-illy-legal-tussle-intensifies/

AstraZeneca improves diabetes pen to maintain its market share

https://pharmaphorum.com/news/astrazeneca-improves-diabetes-pen-to-maintain-its-market-share/

FDA warns of genital gangrene risk with diabetes drug class

https://pharmaphorum.com/news/risk-sglt2-inhibitors-fda-warns/

Merck launches map4health diabetes mobile app

https://pharmaphorum.com/news/merck-launches-map4health-diabetes-mobile-app/

Novo’s oral semaglutide on target in phase 3 trial

https://pharmaphorum.com/news/novos-oral-semaglutide-target-phase-3-trial/

Search